Press release
Antidiabetics Market : Study on Key Players | Sanofi Aventis, Takeda Pharmaceutical, Eli Lilly, Oramed Pharmaceuticals Inc., Boehringer Ingelheim, Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme Therapeutics, Pfizer, AstraZeneca, Johnson &
Increasing number of obese and diabetic patients coupled with rising patient awareness levels serve as high impact rendering factors for antidiabetic market growth over the forecast period.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/504
Favorable government initiatives such as Diabetes Prevention Program (DPP) that aims to help individuals with prediabetes, reduces their risk to develop type 2 diabetes. Trained lifestyle coach works with participants and communicate lifestyle skills, such as, eating healthy food, physical activity and managing stress. Such initiatives should propel industry growth over the forecast period.
Advent of new technologies in products like long acting insulin analogs as well as rapid acting with increased effectiveness should drive industry growth over the forecast timeframe. The novel insulin pen technology permits low-pain and suitable daily insulin injection that should upsurge therapy sales. Type 2 diabetes mellitus (T2DM) has strong familial aggregation, the person with a parent or sibling with disease are at high risk. People with obesity, hypertension, or dyslipidemia and women with history of gestational diabetes are also at high risk to develop T2DM.
Long-acting insulin provide basal insulin coverage. Basal insulin suppresses hepatic gluconeogenesis and prevent increase in glucose level during fasting state in insulin-deficient patients. Long acting insulin analog includes insulin glargine (Lantus) and insulin detemir (Levemir) which will drive industry growth.
Biguanides should contribute for significant revenue share in 2016. It is colorless solid and prevents production of glucose in liver. Biguanides are administered orally for the treatment of type 2 diabetes. It helps in improving sensitivity of body towards insulin and decreases amount of sugar absorbed in intestines and will increase demand for such antidiabetic drugs.
U.S. antidiabetics market size valued over USD 19.4 billion in 2016 and expected to grow significantly over the coming years. Increased healthcare expenditure along with availability of improved healthcare infrastructure and favorable reimbursement policies should drive antidiabetics market size.
UK contributed for significant revenue share in 2016. The growth is attributed due to wide range of funds offered by Diabetes UK for research related to the treatment of diabetes and its complications. In November 2016, the Prime Minister introduced new Diabetes UK office on World Diabetes Day.
Japan antidiabetics market should grow at significant rate over the forecast period. Diabetic population is on rise due to lifestyle changes that will accompany economic growth and drive antidiabetic market growth. The Japan Diabetes Society (JDS) encourage progress and development of diabetes study and prevent people from disease in the country.
Brazil contributed for significant revenue share. The growth is attributed due to early adoption of insulin analogues and increased use of these products in the country.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/504
Some of the companies operating in antidiabetics market include Eli Lilly, Pfizer, Novo Nordisk, Takeda Pharmaceuticals, Sanofi Aventis, Merck, Boehringer Ingelheim and Oramed Pharmaceuticals.
Report Content
Chapter 1. Methodology
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical modeling and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
Chapter 2.Executive Summary
2.1. Antidiabetics industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Regional trends
Chapter 3. Antidiabetics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Gradual increase in prevalence of diabetes
3.3.1.2. Presence of strong product pipeline portfolio
3.3.1.3. Increasing prevalence of lifestyle induced disorders such as obesity
3.3.2. Industry pitfalls & challenges
3.3.2.1. High insulin prices
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By application
3.5. Regulatory landscape
3.5.1. U.S
3.5.2. Europe
3.6. Reimbursement scenario
3.6.1. U.S
3.6.2. Europe
3.7. Pipeline overview
3.8. Porter’s analysis
3.9. Competitive landscape, 2016
3.9.1. Business overview
3.9.2. Revenue analysis
3.9.3. Product landscape
3.9.4. Strategy dashboard
3.10. PESTEL analysis
Chapter 4. Antidiabetics Market, By Product
4.1. Global antidiabetics market share, by product, 2016 & 2024
4.2. Insulin
4.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.2.2. Rapid acting analog
4.2.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.2.3. Long acting analog
4.2.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.2.4. Premixed analog
4.2.4.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.2.5. Premixed insulin
4.2.5.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.2.6. Short acting analog
4.2.6.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.2.7. Intermediate acting insulin
4.2.7.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3. Others
4.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3.2. Alpha glucosidase inhibitors
4.3.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3.3. Biguanides
4.3.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3.4. Sulphonylureas
4.3.4.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3.5. GLP-1 (Glucagon like peptide) agonists
4.3.5.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3.6. DPP-IV (Dipeptidyl Peptidase) inhibitors
4.3.6.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3.7. Meglitinides
4.3.7.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3.8. SGLT-II (Sodium Glucose Transport Proteins) inhibitors
4.3.8.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
4.3.9. Thiazolidinedione
4.3.9.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
Chapter 5. Antidiabetic Market, By Application
5.1. Global antidiabetics market share, by application, 2016 & 2024
5.2. Type I diabetes
5.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
5.3. Type II diabetes
5.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antidiabetics Market : Study on Key Players | Sanofi Aventis, Takeda Pharmaceutical, Eli Lilly, Oramed Pharmaceuticals Inc., Boehringer Ingelheim, Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme Therapeutics, Pfizer, AstraZeneca, Johnson & here
News-ID: 1250287 • Views: …
More Releases from Global Market Insights, Inc.
Hepatitis B Vaccine Market Set to Surpass $12 Billion by 2034
The global hepatitis B vaccine market is poised for significant expansion over the next decade, fueled by rising liver disease cases, expanded immunization coverage, and advancements in vaccine development. Valued at USD 6.7 billion in 2024, the market is projected to reach USD 7.3 billion in 2025 and surge to USD 12 billion by 2034, reflecting a healthy compound annual growth rate (CAGR) of 5.7%.
A major driver behind this growth…
Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health.
This in turn has led to a surge in demand for various functional foods…
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock.
According to Global Market Insights Inc estimates…
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight.
Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091
Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population?
The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
